Fibrostenotic Crohn's Disease (FSCD) Market Outlook & - openPR.com
People with Crohn's disease often develop intestinal fibrosis and strictures that current drugs don't reverse; a growing drug pipeline aiming at anti‑fibrotic therapies could change future treatment options.